Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00478673 · ClinicalTrials.gov registry record · Phase 4
Post-Approval Study of the NexStent Carotid Stent System and the FilterWire EZ Embolic Protection System: SONOMA
A Phase 4 study, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- Phase 4
- Development phase
- 298
- Enrollment target
NCT00478673 is a Phase 4 study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 298 participants.
The verdict
NCT00478673, a Phase 4 study, was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 298 participants
- Enrollment target
Study Summary
The primary objective of the SONOMA Registry is to confirm the safety of the NexStent® Carotid Stent System and FilterWire EZ™ Embolic Protection System in routine clinical practice and to identify rare or unanticipated device-related events that might occur.
Interventions
- DEVICE NexStent Carotid Stent System (Monorail Delivery System)
- DEVICE FilterWire EZ™ Embolic Protection System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00478673
The ClinicalTrials.gov registry entry for NCT00478673 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 298 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NexStent Carotid Stent System (Monorail Delivery System) is the first listed.
NCT00478673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00478673 about?
NCT00478673 is a clinical study titled "Post-Approval Study of the NexStent Carotid Stent System and the FilterWire EZ Embolic Protection System: SONOMA". The primary objective of the SONOMA Registry is to confirm the safety of the NexStent® Carotid Stent System and FilterWire EZ™ Embolic Protection System in routine clinical practice and to identify rare or unanticipated device-related events that might occur.
What is the current status of trial NCT00478673?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 298 participants. The study started on 2007-05. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00478673?
The interventions under investigation include: NexStent Carotid Stent System (Monorail Delivery System) (DEVICE), FilterWire EZ™ Embolic Protection System (DEVICE).
Who is sponsoring clinical trial NCT00478673?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.